Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Eddingpharm
Medical Sales Face New Scrutiny As China Cracks Down On Reps, Contract Sellers
A new campaign and proposed law to rein in pharma sales activities in China indicates a new round of regulatory tightening as companies start to resume commercial operations post the coronavirus outbreak.
New China Law Cracks Down On Fake Academic Promotion
Latest regulation aiming to rein in medical sales indicated new round of regulatory tightening in China as pharma firms resume post-coronavirus commercial operations.
China Coronavirus Cases Up Sharply As Pharma Rushes To Aid
AbbVie’s HIV therapy Kaletra is now being used by the Chinese government to treat coronavirus-infected patients after a respiratory expert endorsed its use, while other pharma companies from Bayer to Innovent are showering support as China battles its worst virus outbreak since the SARS epidemic 17 years ago.
Vascepa Included In European Dyslipidemia Guidelines Ahead Of Approval
Amarin won't seek approval in the EU until later this year, but doctors there are encouraged to consider Vascepa for patients with high triglycerides despite statin therapy. Also, PCSK9 inhibitor guidelines were solidified for very high risk patients.
- OTC, Consumer
- Specialty Pharmaceuticals
- Other Names / Subsidiaries
- Eddingpharm (U.S.) Company
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.